Abstract
The ganglioside composition of seven experimental brain tumors was examined in C57BL/6J mice. The tumors were produced from 20-methylcholanthrene (20-MC) implantation into either the cerebrum or cerebellum and were maintained in serial transplants through many generations. The tumors studied were grown subcutaneously as solid tumors, and cells from two of the tumors were also studied in culture. Histologically, all of the tumors were similar and could be broadly classified as highly malignant, poorly differentiated anaplastic astrocytomas. The total ganglioside sialic acid content of the solid tumors was markedly lower than that in adult mouse brain. In addition toN-acetylneuraminic acid (NeuAc), the gangliosides in the solid tumors contained significant amounts ofN-glycolylneuraminic acid (NeuGc). The seven solid tumors fell into two general groups with respect to ganglioside composition. Furthermore, the differences in ganglioside composition between the two tumor groups were strongly associated with differences in tumor cell cohesion. The tumors in one group had high levels of GM3 hematosides, low levels of oligosialogangliosides, and grew as firm cohesive tissues. The tumors in the other group, however, had lower levels of GM3 hematosides, noticeable amounts of oligosialogangliosides and grew as soft noncohesive tissues. In culture, clonal cells from one of the tumors in the first group grew as clumps or islands and contained GM3 as the only major ganglioside, whereas clonal cells from a tumor in the second group grew as sheets or monolayers and contained little GM3, but expressed several gangliosides with complex structures. In marked contrast to the gangliosides in the solid tumors, the gangliosides in the cultured tumor cells contained trace amounts of NeuGc. Since NeuGc containing gangliosides are abundant in mouse nonneural tissues, the high content of NeuGc gangliosides in the solid tumors may arise from infiltration of nonneural tissue elements, e.g., macrophages, lymphocytes, and endothelial cells.
Similar content being viewed by others
Abbreviations
- NeuAc:
-
N-acetylneuraminic acid
- NeuGc:
-
N-glycolylneuraminic acid
References
Ando S. and Yu R. K. (1977) Isolation and characterization of a novel trisialoganglioside, GT1a, from human brain.J. Biol. Chem. 252, 6247–6250.
Ando S., Chang N. C., and Yu R. K. (1978) High performance thin layer chromatography and densitometric determination of brain ganglioside compositions of several species.Anal. Biochem. 89, 427–450.
Ando S. and Yu R. K. (1979) Isolation and characterization of two isomers of brain tetrasialogangliosides.J. Biol. Chem. 254, 12224–12229.
Aruna R. M. and Basu D. (1975). Glycolipid metabolism in tumours of central nervous system.Ind. J. Biochem. Biophys. 13, 158–160.
Asou H. and Brunngraber E. G. (1983) Absence of ganglioside GM1 in astroglial cells from 21-day old rat brain.Neurochem. Res. 8, 1045–1057.
Berra B., Riboni L., De Gasperi R., Gaini S. M., and Ragnotti G. (1983) Modifications of ganglioside patterns in human meningiomas.J. Neurochem. 40, 777–782.
Berra B., Gaini S. M., and Riboni L. (1985) Correlation between ganglioside distribution and histological grading of human astrocytomas.Int. J. Cancer 36, 363–366.
Cheresh D. A., Pierschbacher M. D., Herzig M. A., and Kalplana M. (1986) Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.J. Cell Biol. 102, 688–696.
Chou K. H., Ambers S. A., and Jungalwala F. B. (1979) Ganglioside composition of chemically induced rat neural tumors and characterization of hematoside from neurinomas.J. Neurochem. 33, 863–873.
Crafts D. and Wilson C. B. (1977) Animal models of brain tumors.Natl. Cancer Inst. Monogr. 46, 11–17.
Dawson G., Kemp S. F., Stoolmiller A. C., and Dorfman A. (1971) Biosynthesis of glycosphingolipids by mouse neuroblastoma (NB41A), rat glia (RGC-6) and human glia (CHB-4) in cell culture.Biochem. Biophys. Res. Commun. 44, 687–694.
Dawson G. and Stoolmiller A. C. (1976) Comparison of the ganglioside composition of established mouse neuroblastoma cell strains growingin vivo and in tissue culture.J. Neurochem. 26, 225–226.
Dawson G. (1979) Regulation of glycosphingolipid metabolism in mouse neuroblastoma and glioma cell lines.J. Biol. Chem. 254, 155–162.
Dimpfel W. (1982) Differential distribution of gangliosides in nerve-cell cultures.Cell Molec. Neurobiol. 2, 105–113.
Dreyfus H., Louis J. C., Harth S., and Mandel, P. (1980) Gangliosides in cultured neurons.Neuroscience 5, 1647–1655.
Duffard R. O., Fishman P. H., Bradley R. M., Lauter C. J., Brady R. O., and Trams E. G. (1977) Ganglioside composition and biosynthesis in cultured cells derived from CNS.J. Neurochem. 28, 1161–1166.
Eto Y. and Shinoda S. (1982) Gangliosides and neutral glycolipids in human brain tumors: specificity and their significance.Adv. Exp. Med. Biol. 152, 279–290.
Flavin H. J., Wieraszko A., and Seyfried T. N. (1991) Enhanced aspartate release from hippocampal slices of epileptic (EI) mice.J. Neurochem. 56, 1007–1011.
Fredman P. (1988) Gangliosides in human malignant gliomas, inNew Trends in Ganglioside Research: Neurochemical and Neurogenerative Aspects (Ledeen R. W., Hogan E. L., Tettamanti G., Yates A., and Yu R. K., eds.) pp. 151–161, Liviana, Padova.
Fredman P., von Holst H., Collins V. P., Ammar A., Dellheden B., Wahren B. Granholm L., and Svennerholm L. (1986) Potential ganglioside antigens associated with human gliomas.Neurol. Res. 8, 123–126.
Fredman P., von Holst H., Collins P. V., Granholm L., and Svennerholm L. (1989) Sialosyllactotetraosylceramide, a ganglioside marker for human malignant gliomas.J. Neurochem. 50, 912–919.
Galloway P. G. and Roessmann U. (1986) Anaplastic astrocytoma mimicking metastatic carcinoma.Am. J. Surg. Pathol. 10, 728–732.
Gaini S. M., Riboni L., Ceri C., Grimoldi N., Sganzerla E. P., and Berra B. (1988) Ganglioside content and composition in human gliomas.Acta Neurochirurg.43 (Suppl.), 126–129.
Gottfries J., Fredman P., Mansson J. E., Collins P. V., von Holst H., Armstrong D. D., Percy A. K., Wikstrand C. J., Bigner D. D., and Svennerholm L. (1990) Determination of gangliosides in six human primary medulloblastomas.J. Neurochem. 55, 1322–1326.
Hakomori S. I. and Kannagi R. (1983) Glycosphingolipids as tumor-associated and differentiated markers.J. Natl. Cancer Inst. 71, 231–251.
Hamanaka S., Handa S., and Yamakawa T. (1979) Ganglioside compositions of erythrocytes from various strains of inbred mice.J. Biochem. 86, 1623–1626.
Hirabayashi Y., Taki T., Matsumoto M., and Kojima K. (1977) Comparative study on glycolipid composition, between two cell types of rat ascites hepatoma cells.Biochim. Biophys. Acta 529, 96–105.
Huang R. T. C. (1978) Cell adhesion mediated by glycolipids.Nature 276, 624–626.
Iglesias J. R., Pfannkuch F., Aruffo C., Kazner E., and Navarro J. (1986) Histopathological diagnosis of brain tumors with the help of a computer: mathematical fundamentals and practical application.Acta Neuropathol. 71, 130–135.
Jennemann R., Rodden A., Bauer B. L., Mennel H. D., and Wiegandt H. (1990) Glycosphingolipids of human gliomas.Cancer Res. 50, 7444–7449.
Kawai T., Kato A., Higashi H., Kato S. and Naiki M. (1991) Quantitative determination of N-glycolylneuraminic acid expression in human cancerous tissues and avain lymphoma cell lines as a tumor-associated sialic acid by gas chromatography-mass spectrometry.Cancer Res. 51, 1242–1246.
Kojima N. and Hakomori S.-I. (1989) Specific interaction between gangliotriaosylceramide (Gg3) and sialosyllactosylceramide (GM3) as a basis for specific cellular recognition between lymphoma and melanoma cells.J. Biol. Chem. 264, 20159–20162.
Kostic D. and Buchheit F. (1970) Gangliosides in human brain tumors.Life Sci. 9, 589–596.
Ladish S. (1989) Tumor gangliosides; Shedding, structural characterization and immunosuppressive activity, inGangliosides and Cancer (H. F. Oettgen, ed.) pp. 219–229, VCH, New York.
Ledeen R. W., Yu R. K., and Eng L. F. (1973) Gangliosides of human myelin: sialosygalactosylceramide (G7) as a major component.J. Neurochem. 21, 829–839.
Mandel P., Dreyfus H., Yusuf A. N. K., Sarlieve L., Robert J., Neskovic J, Harth S., and Rebel G. (1980) Neuronal and glial cell cultures, a tool for investigation of ganglioside function.Adv. Exp. Biol. Med. 125, 515–531.
Mansson J. E., Fredman P., Bigner D. D., Molin K., Rosengren B., Friedman H. S., and Svennerholm L. (1986). Characterization of new gangliosides of the lactotetraose series in murine xenographs of a human glioma cell line.FEBS Lett. 201, 109–113.
Manuelidis L., Yu R. K., and Manuelidis E. E. (1977) Ganglioside content and pattern in human gliomas in culture.Acta Neuropath. (Berl.)38, 129–135.
Miller-Podraza H., Bradley R., and Fishman P. (1982) Biosynthesis and localization of gangliosides.Biochemistry 21, 3260–3265.
Nilsson O., Mansson J. E., Lindholm L., Holmgren J., and Svennerholm L. (1985) Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody.FEBS Lett. 182, 398–402.
Okada Y, Mugnai G., Bremer E. G., and Hakomori D. (1984) Glycosphingolipids in detergent-insoluble substrate attachment matrix (DISAM) prepared from substrate attachment material (SAM).Exp. Cell Res. 155, 448–456.
Reynolds B. A. and Weiss S. (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system.Science 255, 1707–1710.
Robert J., Freysz L., Sensenbrenner M., Mandel P., and Rebel G. (1975) Gangliosides of glial cells: A comparative study of normal astroblasts in tissue culture and glial cells isolated on sucrose-ficoll gradients.FEBS Lett. 50, 144–146.
Robert J., Rebel G., and Mandel P. (1977) Glycosphingolipids from cultured astroblasts.J. Lipid Res. 18, 517–522.
Roessmann U., Velasco M. E., Gambetti P., and Autilio-Gambetti L. (1983) Neuronal and astrocytic differentiation in human neuroepithelial neoplasms.J. Neuropathol. Exp. Neurol. 42, 113–121.
Rorke L. B. (1983) The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors.J. Neuropathol. Exp. Neurol. 42, 1–15.
Roseman S. (1970) The synthesis of complex carbohydrates by multiglycosyl-transferase systems and their potential function in intracellular adhesion.Chem. Phys. Lipids 5, 270–297.
Rubin R., Sutton C. H., and Zimmerman H. M. (1968) Experimental ependymoblastoma (fine structure).J. Neuropathol. Exp. Neurol. 27, 421–438.
Rubinstein L. J. (1977) Correlation of animal brain tumor models with human neuro-oncology.Natl. Cancer Inst., Monogr. 46, 43–49.
Rutishauser U., Acheson A., Hall A. K., Mann D. M., and Sunshine J. (1988) The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions.Science 240, 53–57.
Sbaschnig-Agler M., Dreyfus H., Norton W. T., Sensenbrenner M., Farooq M., Byrne M., and Ledeen R. W. (1988) Gangliosides of cultured astroglia.Brain Res. 461, 98–106.
Schauer R. (1985) Sialic acids and their roles as biological masks.Trends Biochem. Sci. 10, 357–360.
Schengrund C. L. and Nelson J. T. (1976) Sialidase activity in mouse neuroblastoma cell lines.Neurochem. Res. 1, 181–190.
Schengrund C. L., Repman M. A., and Shochat S. J. (1985) Ganglioside composition of human neuroblastomas.Cancer 56, 2640–2646.
Schold S. C. and Bigner D. D. (1983) A review of animal brain tumor models that have been used for therapeutic studies, inOncology of the Nervous System (Walker M. D., ed.) pp. 31–64, Martinus Nijhoff, Boston.
Schulz G., Cheresh D. A., Varki N. M., Yu A., Staffileno L. K., and Reisfeld R. A. (1984) Detection of ganglioside GD2 in tumor tissue and sera of neuroblastoma patients.Cancer Res. 44, 5914–5920.
Schwarting G. A. and Gajewski A. (1983) Glycolipids of murine lymphocyte subpopulations.J. Biol. Chem. 258, 5693–5698.
Seyfried T. N., Ando S., and Yu R. K. (1978a) Isolation and characterization of human liver hematoside.J. Lipid Res. 19, 538–543.
Seyfried T. N., Glaser G. H., and Yu R. K. (1978b) Cerebral, cerebellar, and brain stem gangliosides in mice susceptible to audiogenic seizures.J. Neurochem. 31, 21–27.
Seyfried T. N., Itoh T., Miyazawa N., and Yu R. K. (1981) Cerebellar gangliosides and phosopholipids in mutant mice with ataxia and epilepsy: The tottering/leaner syndrome.Brain Res. 216, 429–436.
Seyfried T. N., Yu R. K., Saito M., and Albert M. (1987) Ganglioside composition of an experimental mouse brain tumor.Cancer Res. 47, 3538–3542.
Seyfried T. N., Roy M. L., and El-Abbadi M. (1991) Ganglioside composition of neural tumors in mice.Trans. Am. Soc. Neurochem. 22, 269.
Shochat S. J., Corbelleta N. L., Repman M. A., and Schengrund C. L. (1987) A biochemical analysis of thoracic neuroblastomas: A pediatric oncology group of study.J. Ped. Surg. 22, 660–664.
Stoolmiller A. C., Dawson G., Kemp S. F., and Schachner M. (1979) Synthesis of glycosphingolipids in mouse glial tumors.J. Neurochem. 32, 637–641.
Traylor T. D. and Hogan E. L. (1980) Gangliosides of human astrocytomas.J. Neurochem. 34, 126–131.
Tsuchida T., Ravindranath M. H., Saxton R. E. and Irie R. (1987) Gangliosides of human melanoma: Altered expressionin vivo andin vitro.Cancer Res. 47, 1278–1281.
Ueno K., Ando S., and Yu R. K. (1978) Gangliosides of human, cat and rabbit spinal cords and cord myelin.J. Lipid Res. 19, 863–871.
Van Echten G. and Sandhoff K. (1989) Modulation of ganglioside biosynthesis in primary cultured neurons.J. Neurochem. 52, 207–214.
Wu Z. L., Schwartz E., Seeger R., and Ladisch S. (1986) Expression of GD2 by untreated primary human neuroblastomas.Cancer Res. 46, 440–443.
Yamasaki T., Handa H., Yamashita J., Watanabe Y., Namba Y., and Hanaoka M. (1984) Specific adoptive immunotherapy with tumor-specific cytotoxic T-lymphocyte clone for murine malignant gliomas.Cancer Res. 44, 1776–1783.
Yates A. J. (1988) Glycolipids and gliomas: A review.Neurochem. Pathol. 8, 157–179.
Yates A. J., Thompson D. K., Boesel C. P., Albrightson C., and Hart R. W. (1979) Lipid composition of human neural tumors.J. Lipid Res. 20, 428–436.
Yogeeswaran G., Wherrett J. R., Chatterjee S., and Murry, R. K. (1970) Ganglioside of cultured mouse cells: Partial characterization and demonstration of14C-glucosamine incorporation.J. Biol. Chem. 245, 6718–6725.
Yogeeswaran G., Murry R. K., Pearson M. L., Sanwal B. D., McMorris F. A., and Ruddle F. H. (1973) Glycospingolipids of clonal lines of mouse neuroblastoma and neuroblastoma XL cell hybrids.J. Biol. Chem. 248, 1231–1239.
Yohe H. C., Coleman D. L., and Ryan J. (1985) Ganglioside alteration in stimulated murine macrophages.Biochem. Biophys. Acta 818, 81–86.
Yohe H. C. and Ryan J. L. (1986) Ganglioside expression in macrophages from endotoxin responder and nonendotoxin responder mice.J. Immunol. 127, 3921–3927.
Yu R. K., and Ledeen R. W. (1970) Gas-liquid chromatographic assay of lipid-bound sialic acids: Measurement of gangliosides in brains of several species.J. Lipid Res. 11, 506–516.
Zimmerman H. M. and Arnold H. (1941) Experimental brain tumors: I. Tumors produced with methylcholanthrene.Cancer Res. 1, 919–938.
Zulch K. J. (1980) Principles of the new World Health Organization (WHO) classification of brain tumors.Neuroradiology 19, 59–66.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seyfried, T.N., El-Abbadi, M. & Roy, M.L. Ganglioside distribution in murine neural tumors. Molecular and Chemical Neuropathology 17, 147–167 (1992). https://doi.org/10.1007/BF03159989
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03159989